Current status on histological classification in Cushing’s disease

详细信息    查看全文

• 作者：Luis V. Syro ; Fabio Rotondo ; Michael D. Cusimano ; Antonio Di Ieva ; Eva Horvath…
• 关键词：Classification ; Cushing’s disease ; Diagnosis ; Pathology ; Pituitary tumor
• 刊名：Pituitary
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：18
• 期：2
• 页码：217-224
• 全文大小：1,089 KB
• 参考文献：1. Cushing, H (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50: pp. 137-195
  2. Bertagna, X, Guignat, L (2013) Approach to the Cushing’s disease patient with persistent/recurrent hypercortisolism after pituitary surgery. J Clin Endocrinol Metab 98: pp. 1307-1318 dx.doi.org/10.1210/jc.2012-3200" target="_blank" title="It opens in new window">CrossRef
  3. Gadelha, MR, Vieira Neto, L (2014) Efficacy of medical treatment in Cushing’s disease: a systematic review. Clin Endocrinol 80: pp. 1-12 dx.doi.org/10.1111/cen.12345" target="_blank" title="It opens in new window">CrossRef
  4. Fleseriu, M, Petersenn, S (2013) New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy. J Neurooncol 114: pp. 1-11 dx.doi.org/10.1007/s11060-013-1151-1" target="_blank" title="It opens in new window">CrossRef
  5. Feelders, RA, Hofland, LJ (2013) Medical treatment of Cushing’s disease. J Clin Endocrinol Metab 98: pp. 425-438 dx.doi.org/10.1210/jc.2012-3126" target="_blank" title="It opens in new window">CrossRef
  6. Fleseriu, M, Petersenn, S (2012) Medical management of Cushing’s disease: what is the future?. Pituitary 15: pp. 330-341 dx.doi.org/10.1007/s11102-012-0397-5" target="_blank" title="It opens in new window">CrossRef
  7. Cuevas-Ramos, D, Fleseriu, M (2014) Treatment of Cushing’s disease: a mechanistic update. J Endocrinol 223: pp. R19-R39 dx.doi.org/10.1530/JOE-14-0300" target="_blank" title="It opens in new window">CrossRef
  8. Nieman, LK (2013) Update in the medical therapy of Cushing’s disease. Curr Opin Endocrinol Diabetes Obes 20: pp. 330-334
  9. Mete, O, Asa, SL (2013) Therapeutic implications of accurate classification of pituitary adenomas. Semin Diagn Pathol 30: pp. 158-164 dx.doi.org/10.1053/j.semdp.2013.06.002" target="_blank" title="It opens in new window">CrossRef
  10. Mete, O, Asa, SL (2012) Clinicopathological correlations in pituitary adenomas. Brain Pathol 22: pp. 443-453 dx.doi.org/10.1111/j.1750-3639.2012.00599.x" target="_blank" title="It opens in new window">CrossRef
  11. Asa SL (2011) Tumors of the pituitary Gland, vol. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC
  12. Osamura, RY, Kajiya, H, Takei, M, Egashira, N, Tobita, M, Takekoshi, S, Teramoto, A (2008) Pathology of the human pituitary adenomas. Histochem Cell Biol 130: pp. 495-507 dx.doi.org/10.1007/s00418-008-0472-1" target="_blank" title="It opens in new window">CrossRef
  13. Syro, LV, Builes, CE, Ieva, A, Sav, A, Rotondo, F, Kovacs, K (2014) Improving differential diagnosis of pituitary adenomas. Expert Rev Endocrinol Metab 9: pp. 377-386 dx.doi.org/10.1586/17446651.2014.922412" target="_blank" title="It opens in new window">CrossRef
  14. Cuevas-Ramos, D, Fleseriu, M (2014) Somatostatin receptor ligands and resistance to treatment in pituitary adenomas. J Mol Endocrinol 52: pp. R223-R240 dx.doi.org/10.1530/JME-14-0011" target="_blank" title="It opens in new window">CrossRef
  15. Chinezu, L, Vasiljevic, A, Jouanneau, E, Francois, P, Borda, A, Trouillas, J, Raverot, G (2014) Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies. Hum Pathol 45: pp. 71-77 dx.doi.org/10.1016/j.humpath.2013.08.007" target="_blank" title="It opens in new window">CrossRef
  16. Mete, O, Ezzat, S, Asa, SL (2012) Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol 49: pp. R69-R78 dx.doi.org/10.1530/JME-12-0113" target="_blank" title="It opens in new window">CrossRef
  17. Sav, A, Rotondo, F, Syro, LV, Scheithauer, BW, Kovacs, K (2012) Biomarkers of pituitary neoplasms. Anticancer Res 32: pp. 4639-4654
  18. Takeshita, A, Inoshita, N, Taguchi, M, Okuda, C, Fukuhara, N, Oyama, K, Ohashi, K, Sano, T, Takeuchi, Y, Yamada, S (2009) High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing’s disease. Eur J Endocrinol 161: pp. 553-559 dx.doi.org/10.1530/EJE-09-0414" target="_blank" title="It opens in new window">CrossRef
  19. Salehi, F, Scheithauer, BW, Kovacs, K, Horvath, E, Syro, LV, Sharma, S, Manoranjan, B, Cusimano, M (2012) O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas. Neu
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Diabetes
  Neurosurgery
  
• 出版者：Springer Netherlands
• ISSN：1573-7403

文摘

Introduction Managing Cushing’s disease remains a challenge. Surgery is the first option of treatment and it offers a high success rate. Even in cases where biochemical remission is not achieved, it is crucial to obtain surgical tissue for morphological diagnosis because the therapeutic approach can be modified according to the findings. Materials and Methods A literature search was performed using PubMed for information regarding pathology and Cushing’s disease. Results The histopathological features found in the pituitary gland of patients with Cushing’s disease are presented. Conclusion Different subtypes of ACTH-producing pituitary tumors are recognized and characterized. The significance of finding a normal pituitary gland with or without Crooke’s changes is also discussed.